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Background: Whereas mutations affecting the helical domain of type I procollagen classically cause Osteogenesis
Imperfecta (OI), helical mutations near the amino (N)-proteinase cleavage site have been suggested to result in a
mixed OI/Ehlers-Danlos syndrome (EDS)-phenotype.
Methods: We performed biochemical and molecular analysis of type I (pro-) collagen in a cohort of seven patients
referred with a clinical diagnosis of EDS and showing only subtle signs of OI. Transmission electron microscopy of
the dermis was available for one patient.
Results: All of these patients harboured a COL1A1 / COL1A2 mutation residing within the most N-terminal part of
the type I collagen helix. These mutations affect the rate of type I collagen N-propeptide cleavage and disturb
normal collagen fibrillogenesis. Importantly, patients with this type of mutation do not show a typical OI phenotype
but mainly present as EDS patients displaying severe joint hyperlaxity, soft and hyperextensible skin, abnormal
wound healing, easy bruising, and sometimes signs of arterial fragility. In addition, they show subtle signs of OI
including blue sclerae, relatively short stature and osteopenia or fractures.
Conclusion: Recognition of this distinct phenotype is important for accurate genetic counselling, clinical
management and surveillance, particularly in relation to the potential risk for vascular rupture associated with these
mutations. Because these patients present clinical overlap with other EDS subtypes, biochemical collagen analysis is
necessary to establish the correct diagnosis.
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PhenotypeBackground
Type I collagen is the most abundant extracellular matrix
(ECM) protein in humans and the major structural pro-
tein of bone, tendon, skin and cornea. It is a heterotrimer
consisting of two α1-chains and one α2-chain, encoded by
COL1A1 (MIM: 120150) and COL1A2 (MIM: 120160) re-
spectively. The precursor form, type I procollagen, con-
tains a central helical domain, flanked by an amino-(N)* Correspondence: Fransiska.Malfait@Ugent.be
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reproduction in any medium, provided the orand carboxy-(C) terminal propeptide. The central helical
domain consists of a repeating [Gly-X-Y] triplet in which
glycine is the only amino acid small enough to reside
within the sterically restricted inner aspect of the helix.
Type I procollagen molecules are synthesized and folded
in the rough endoplasmic reticulum, where they are modi-
fied by hydroxylating and glycosylating enzymes and are
then secreted into the ECM. After cleavage of the N- and
C-terminal propeptide by specific N- and C-proteinases,
they are converted to mature collagen molecules, which
self-assemble into fibrils.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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duce a range of disorders, which include autosomal dom-
inant (AD) osteogenesis imperfecta (OI) and the rare
arthrochalasis subtype of EDS. OI comprises a spectrum
of mild to lethal phenotypes, characterized by a variable
degree of bone fragility with susceptibility to bone frac-
tures, growth deficiency, blue sclerae, hearing deficit and
dentinogenesis imperfecta. Over 1000 distinct mutations
in the primary genetic sequence of COL1A1 and COL1A2
have been identified in one or different OI variants [1,2]
(Dalgleish R.: Osteogenesis Imperfecta Variant Database
(https://oi.gene.le.ac.uk, accessed January 21st 2013). The
most frequent type of mutations are missense mutations
that cause the substitution of one of the crucial helical gly-
cine residues by a bulkier amino acid, nonsense mutations
which result in a non-functional COL1A1 allele or splicing
mutations which lead to exon-skipping [3]. They are
widespread over the COL1A1 and COL1A2 genes, includ-
ing mainly the helical- and, to a lesser extent, the C-
propeptide-encoding region of the genes.
In contrast, the rare EDS arthrochalasis subtype results
from a specific type of mutation in either COL1A1 or
COL1A2, which causes complete or partial skipping of
exon 6, encoding the procollagen type I-N-proteinase
cleavage site [4]. Due to loss of the cleavage site, the
processing of either the proα1(I) or the proα2(I)
N-propeptide is abolished and incompletely processed
procollagen chains, in which the C-propeptide but not
the N-propeptide has been cleaved off, are secreted and
incorporated into the growing collagen fibrils. The
phenotype of this rare EDS variant is characterized by
severe, generalized joint hypermobility and recurring
joint dislocations, including bilateral congenital hip dis-
location (CHD), skin hyperextensibility, atrophic scar-
ring, mild dysmorphic features, short stature, blue
sclerae and osteopenia [5,6].
Occasionally, patients are encountered who display a
phenotype that combines clinical manifestations of both
OI and EDS. The few published reports on such patients
with a mixed OI/EDS phenotype demonstrate that most
of them harbour a mutation in the most N-terminal part
of the type I collagen helical region in either the α1- or
α2- chain, which affects to some extent proper processing
of the N-propeptide [7-12].
Here we substantially extend the patient cohort with an
OI/EDS overlap syndrome and provide a comprehensive
overview of the clinical, biochemical and molecular char-
acteristics of type I collagen mutations, which cause this
phenotype. Our data show that some patients harbouring
a mutation within this region of the type I collagen mol-
ecule predominantly present with an EDS phenotype that
resembles, but is distinct from other EDS subtypes, both
in clinical spectrum and severity, as in the underlying col-
lagen protein defect.Material and methods
Clinical information
For all probands clinical information was obtained from
physical examination by one of the authors. Informed
consent from the probands and/or their legal guardians
was obtained in accordance with requirements of the
Local Ethics Committees. Skin biopsies were taken from
the probands’ inner aspect of the upper arm for the es-
tablishment of a fibroblast culture. In proband P3, part
of the skin biopsy was prepared for transmission elec-
tron microscopy (TEM).Biochemical studies and ultrastructural studies
Fibroblast cell culture, steady state collagen labelling and
sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) analysis were performed as described previ-
ously [13]. Briefly, at confluency the patients’ fibroblasts
were labelled with 14C-Proline [14] and intracellular colla-
gen and secreted (pro)collagen proteins were separated on
6% SDS-PAGE gels. The SDS-PAGE-gels were processed
for fluorography, dried, and exposed to an X-ray film.
In order to examine the conversion of procollagen to
collagen by pericellular enzymes, pulse chase analysis was
performed as previously described [7]. Processing of se-
creted procollagens to mature collagen by the procollagen-
I-C-proteinase BMP-1 and the procollagen-I-N-proteinase
ADAMTS2 was studied over a 5-day period. Dermal fib-
roblasts were labelled with 14C-proline for 20 hr and
medium was harvested at 24-hr intervals. Medium pro-
collagen samples were isolated, electrophoresed on 6%
SDS-PAGE gels and visualized by autoradiography.
In proband P3 part of the skip biopsy was prepared for
TEM following fixation in 5% glutaraldehyde in phosphate
buffer at pH 7.4, then fixed in 1% osmium tetroxide for 60
min, dehydrated in acetone and embedded in Epoxy-resin.
Semi-thin sections were stained with 2% methylene blue
in 1% Borax. Examination was performed using a Zeiss
Microscope.Mutation Identification
Total RNA was isolated from cultured skin fibroblasts
from the probands by TRIZOL (Life Technologies). For
the conversion to cDNA, moloney murine leukemia virus
reverse transcriptase (M-MLV-RT) was used in combin-
ation with random hexanucleotide primers. For sequen-
cing at the genomic DNA (gDNA) level, gDNA was
extracted from cultured skin fibroblasts (DNeasy-
Invitrogen) according to the manufacturer’s instructions.
The coding regions (cDNA level) and exons and flanking
introns (gDNA level) of COL1A1 and COL1A2 were PCR
amplified and were separated on agarose (PCR primers
available upon request). The amplimers were sequenced
using the ABI3730XL sequencer.
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of the initiation codon (ATG) of the cDNA reference
sequence. Reference cDNA sequence is based on Gen
bank Accession no.: NM_000088.3 for COL1A1 and
NM_000089.3 for COL1A2. Amino acid residues were
numbered from the first methionine residue of the refer-
ence sequence.
Results
Clinical Description and molecular findings
All probands were referred with a clinical diagnosis of
Ehlers-Danlos syndrome and presented a phenotype
predominated by generalized joint hyperlaxity and skin
hyperextensibility and/or translucency and, in some of
them, also signs of vascular fragility. In addition, all pro-
bands presented with relatively short stature, blue sclerae
and mild signs of bone fragility with osteopenia and/or aTable 1 Clinical characteristics of the probands
P1 P2 P
Patient identifier OI variant
database
AN_001001 AN_001954 A
Gene COL1A1 COL1A1 C
Exon 7 8 7
Mutation p.(G188D) p.(G203C) Sk
Sex M M F
Stature <3rd centile 3rd centile <
Skin/soft tissue
Hyperextensibility and/or translucency + + +
Delayed wound healing, abnormal scarring + + +
Easy bruising + + +
Muscle and joints
Hypotonia + + +
Hypermobility + + +
Dislocations + + +
Scoliosis - + -
CHD - - -
Bone
Fractures + pelvis/
vertebrae
+ (3x) +
o
Cardiovascular
Echocardiography ASD Aortic dilation N
Arterial rupture + - -
Other
Blue sclerae + + +
Hernia - Inguinal -
ASD: atrial septum defect.
CHD: congenital hip dislocation.
NL: normal.
ND: Not done.history of infrequent fractures. These symptoms however
did not predominate the clinical picture, and did not elicit
a clinical diagnosis of OI.
Available clinical findings of the probands are summa-
rized in Table 1 and illustrated in Figure 1.
Proband P1 (Figure 1A) was born at term after an un-
eventful pregnancy and delivery. In early childhood he
displayed generalized joint hypermobility, low muscle
mass and a mild delay in neuromotor development. He
bruised easily and at age 5 yrs, he suffered an epidural
hematoma with intraspinal hemorrhage following a rela-
tively mild trauma, which raised suspicion of vascular
EDS. Clinical investigation at age 6 yrs revealed a short-
statured boy with pale blue sclerae, hypertelorism, a pale
soft and hyperextensible skin with some atrophic scars
and generalized joint hypermobility (Beighton score 8/9).
He suffered one fracture of the foot and recurrent3 P4 P5 P6 P7
N_001096 AN_001060 AN_001955 AN_001062 AN_001956
OL1A2 COL1A2 COL1A2 COL1A2 COL1A2
8 9 12 14
ip ex 7 p.(G109D) Skip ex 9 p.(G196V) Skip ex 14
M M F F
3rd centile NA <3rd centile 3rd centile 3rd-10th centile
+ + + +
- + - -
+ + + +
+ - + -
+ + + +
- + - -
- - - -
- - - -
(late-
nset)
- + (2x) + (4x) +2x
greenstickfracture
L NL NL NL ND
+ - - -
+ + + +
- - - -
Figure 1 Clinical features of the probands. A: P1 at the age of 7 yrs. Note hypertelorism, several bruises on forehead and shins, mild pectus
excavatum and slightly bowed legs. B-D: P2. Note the mildly blue sclerae, prominent forehead, mildly hypertrophic scarring and skin
hyperextensibility. E&L: P3 at the age of 37 yrs. Note the short trunk and mildly atrophic scars on the knees. F-H: P5 at the age of 10 yrs: skin
hyperextensibility, generalized joint hyperlaxity and mildly hypertrophic cicatrisation. I-K: P7 at the age of 7 yrs. She displays blue sclerae and
translucent skin. Note the multiple ecchymoses and hematomas on the legs.
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bone densitometry at the age of 6 yrs showed marked
osteoporosis of the vertebrae, with a DEXA Z-score
of −3.4 SD. At the age of 12 yrs he had a fracture of the
pelvis and compression of several vertebrae for which
bisphosphonate treatment was started. Ultrasonography
of the heart showed an atrial septum defect (ASD) with
right ventricular dilatation. The ASD was surgically closed,
however the first patch loosened, and the boy had to be
re-operated.
Proband P2 (Figure 1B-D) was born at term after an un-
eventful pregnancy and delivery. His gross motor develop-
ment was delayed due to muscle hypotonia. At age 2 yrs
he developed a kyphoscoliosis, which progressed in the
following years. He sustained three fractures, of the right
elbow, and of both femurs, before the age of 5 yrs, for
which treatment with biphosphonates was started. X-rays
showed osteopenia. At the of age 5 yrs 10 months, he
displayed hyperextensible skin, abnormal wound healing,
easy bruising, hyperextensible joints (Beighton score 9/9),
pectus excavatum, long fingers and toes and inguinal her-
nia. In addition he displayed blue sclerae, macrocephaly,
and short stature. Based on these findings he was clinically
suspected to have EDS kyphoscoliotic type. At age 8 yrs,
dilation of the aorta (+2.02 Z-score) was noted.
Proband P3 (Figure 1E&L) was born at term in breech
position and presented with a shoulder dislocation. Dur-
ing childhood marked joint hypermobility, repetitive ankledistortions and easy bruising were noted. Later on, in early
adulthood, she suffered from recurring dislocations of the
wrists, knees and ankles and had a few late-onset fractures
(toe, coccyx and vertebral compression fracture at adult
age). Clinical investigation at age 37 yrs showed a short-
statured woman with pale blue sclerae, a soft and mildly
hyperextensible skin and a small, distended post-operative
scar on the right knee. Joint hypermobility was generalized
with a Beighton score of 8/9. Ultrasonography of the heart
revealed mild mitral valve insufficiency. Bone densitom-
etry at the age of 36 yrs showed marked osteoporosis of
the vertebrae, with a DEXA Z-score of −3.5 SD. The
probands father and paternal grandmother both presen-
ted short stature, blue sclerae, easy bruising and joint
dislocations.
Transmission electron microscopy was performed at
age 37 yrs on a skin biopsy and showed lower collagen fi-
bril density in the dermis than in a skin biopsy from a
control subject. Collagen fibrils had a circular cross-
section, but some fibrils displayed a slightly irregular con-
tour. No cauliflower deformations were observed. The
fibril diameter was distinctly smaller (73.01 +/− 5.88 nm)
than in that of the control sample(s) (97.10 +/− 8.1 nm)
(Figure 2) (courtesy of Prof Dr Yves Vanderhaeghen,
Department of Dermatology, Ghent University Hospital,
Belgium).
Proband P4 was born at term by ceasarian section. He
presented dark blue sclerae, marked generalized joint
Figure 2 Transmission electron microscopy of collagen dermal
fibrils. A: Normal control. Fibril diameter is 97,1 +/− 8,1 nm (original
magnification 45.000x). B: EDS arthrochalasis subtype (VIIB): complete
retention of the N-propeptide of the α2(I)-procollagen chain is
caused by skipping of the N-proteinase cleavage site itself, resulting
in incorporation of pN-collagen molecules into the collagen fibrils in
the extracellular matrix. This causes loss of the normal collagen fibril
morphology, with decreased fibril density, decreased fibril diameter
(43.82 +/− 6.09 nm), irregular contours and occasional cauliflowers
(original magnification 45.000x). C: OI/EDS-proband P3: The N-
proteinase cleavage site remains intact, but processing of the type I
procollagen N-propeptide is delayed, resulting in abnormal collagen
fibrils, with irregular borders and diameters (73.01 +/− 5.88 nm) that
are smaller than those from controls but larger than for patients
with EDS arthrochalasis type. Fibril contours are only slightly irregular
and fibril density is decreased (original magnification 45.000×).
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skin with visible veins on the thorax. At birth his height
was at the 75th centile. On the 3rd day of life he developed
tonic-clonic seizures with opisthotonus. Ultrasonography
of the brain revealed a massive intracranial bleeding, rea-
son for which a diagnosis of vascular EDS was suspected.
At 18 months extremely lax joints, pes planovalgus and
mildly hyperelastic, soft skin were noticed. He also
presented long and thin fingers. At age 7 yrs he had sec-
ondary hydrocephalus, treated with a shunt, axial hypo-
tonia, mild spastic right hemiplegia, focal seizures and
psychomotor delay. Ultrasonography of the heart was nor-
mal and skull X-ray was negative for wormian bones. At
the age of 6 yrs 3 months he exhibited severe lumbar
osteopenia with Z-score −2,1 SD and incipient generalized
osteopenia of −1,1 SD. At 7 yrs weight was at the 30th
centile, length at the 5th centile, and head circumference
at the 3rd centile. While his skin was no longer
hyperelastic, there was some bruisability, slow wound
healing and he presented one atrophic scar on his arm.
His joints were still very lax.
The proband’s mother displayed pale blue sclerae, thin
face with thin and pinched nose, wrinkly skin and a
papyraceous scar on the elbow, extensive striae gra-
vidarum and arachnodactyly. At 18 months of age she
suffered a shoulder dislocation. At adult age, she still
presented extreme generalized joint laxity. She had mitral
valve prolaps with myxomatous degeneration and mild re-
gurgitation. DEXA bone densitometry revealed femoral
osteopenia with Z-score −1,55 SD while the whole body
Z-score was normal. The maternal grandmother of the
proband died at the age of 38 yrs due to rupture of an as-
cending aorta aneurysm. She also had generalized joint
hyperlaxity, short stature and a thin, fragile skin, as did
her brother.
Proband P5 (Figure 1F-H) was born after an uneventful
pregnancy and delivery. At birth, joint hyperlaxity with a
dislocatable patella was noted. At age 9 yrs 5 months he
presented a soft, doughy and hyperextensible skin, with
increased palmar wrinkling, and mild hypertrophic scar-
ring. He displayed generalized joint hyperlaxity with a
Beighton score of 9/9, and a history of dislocated thumbs
and temporomandibular joints. He had a slightly blue
scleral hue, rather short stature, and sustained a
supracondylar humeral fracture at age 2.5 yrs, with a sec-
ond fractures at the same site 6 months later.
Proband P6 was born at term with a height of 47 cm
(<3rd centile) and presented with easy bruising general-
ized joint hypermobility and muscle hypotonia with delay
in gross motor development, reason for which she was re-
ferred to a neurologist. She suffered three nose fractures
and sustained a fracture of the foot after mild trauma.
Clinical examination at age 4 yrs showed a short-statured
girl with blue sclerae and a pale round face. She displayed
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veins on the thorax, as well as marked generalized joint
hypermobility (Beighton score 9/9). She bruised easily and
displayed multiple small hematoma’s on the legs upon
clinical examination. Skeletal X-rays revealed osteopenia
of the spine and mild bowing of the tibia and fibula. Ultra-
sonography of the heart was normal. Family history was
negative for connective tissue weakness.
Proband P7 (Figure 1I-K) was born after an uneventful
pregnancy and delivery. She sustained two greenstick frac-
tures of the ankles at age 4 and 6 yrs respectively. At age 6
yrs, she was clinically suspected to have vascular EDS, be-
cause of a thin, translucent skin with a somewhat
acrogeric aspect on hands and feet and marked bruising
after minor trauma. A small atrophic scar on the leg and
hyperlaxity of the finger joints was noted on clinical exam-
ination. She was rather short-statured (height between 3rd
and 10th centiles) with deep blue sclerae, macrocephalyFigure 3 SDS-PAGE analysis of secreted 14C-labeled (pro)collagen mo
were extracted from the medium fraction of the cell cultures. The globular
pepsin-digestion, resulting in mature triple helical collagen proteins. Lane n
corresponds to control samples. panel A: medium fraction. P2: note the ex
mutant α1(I)-collagen dimers ( indicated by *). EDS VIIA: patient with EDS a
the α1(I) collagen chain that corresponds to mature α-chains and the incom
doublet is absent in the OI/EDS patients. panel B: medium procollagen frac
representing the pNα1(I) chain is increased, whereas the intensity of the ba
This is caused by a disturbed balance in the normal kinetics of the delayed
procollagen. This pattern is similar to what is observed in the patient with
procollagen fraction is shown from a patient with classic OI, without EDS-s
intensity of the bands representing the pNα1-, pCα1- and mature α1 chainhead circumference at 97th centile), frontal bossing, lack
of peri-orbital fat, and pes planus. A skeletal survey at age
8 yrs 4 months revealed Wormian bones in the skull, gen-
eralized osteopenia and mild bowing of the tibia and fibula
diaphyses. Family history was unremarkable for connect-
ive tissue disorders.
Steady-state biochemichal findings
SDS-PAGE analysis of collagens type I and III in the
medium and the cell layer fraction showed a normal as-
pect of the band representing type III collagen in all pro-
bands, making a diagnosis of vascular EDS highly unlikely
(Figure 3A). In contrast, the pattern of pepsin-digested
type I collagen retained in the cells, and secreted in the
medium was abnormal for probands P1, P2, P5 and P6.
Slight differences in the electrophoretic migration pattern
were visible among the different patient samples. In P1
the bands representing the mature α-chains of type Ilecules from dermal fibroblasts. Secreted procollagen molecules
N- and C-propeptide of the procollagen molecules were removed by
umbers correspond to the patient’s numbers in the text; “C”
tra band of higher molecular weight, suggestive for presence of
rthrochalasis type, due to a COL1A1 exon 6 skip: note the “doublet” for
pletely cleaved pNα1(I)-chains (indicated by **) respectively. This
tion. Compared to the control sample, the intensity of the bands
nds representing the pCα1(I) and the mature α1(I)-chain is decreased.
N-processing and the unhampered C-processing of type I
EDS arthrochalasis type (EDS VIIA). In the right panel, the medium
igns, with p.(Gly257Arg) substitution in exon 11 of COL1A1. Here,
s of type I collagens is comparable to that of the control.
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shown) and in the medium fraction, and migrated some-
what faster in comparison to the control. In P2, an extra
band of higher molecular weight, suggestive for presence
of mutant α1(I)-collagen dimers, was observed in both cell
layer (not shown) and medium fraction. In P5 and P6 a
fuzzy and slightly broadened aspect of the bands
representing the α2(I)-collagen chains (in P5) or both α(I)
collagen chains (in P6) was observed in both cell layer
(not shown) and medium.
SDS-PAGE analysis of procollagen type I and III,
extracted from medium and cell layer of the skin fibro-
blast culture, showed a normal aspect of the band
representing type III procollagen in all probands. How-
ever, in all probands, an increased intensity of the bands
representing the pNα1 chains of type I procollagen was
observed compared to the control sample, whereas a de-
creased intensity of the bands representing the pCα1(I)
and the mature α1(I) collagen chains was observed com-
pared to the control sample, which suggested that the
processing of the N-propeptide was delayed (Figure 3B).
In contrast, no differences in intensity of the bands
representing the pNα1- and pCα1-chains were observed
in a patient with classic OI, without overt EDS-signs, with
a p.(Gly257Arg) substitution in exon 11 of COL1A1.
Pulse chase analysis
In order to evaluate the conversion of procollagen to col-
lagen, a pulse chase analysis was performed. The rate of
conversion of procollagen to collagen by the C-proteinaseFigure 4 Pericellular processing of procollagen. The conversion of a pu
The pulse chase analyses are shown for a control sample, P1, P4, and a pat
(EDS VIIB). In the control sample a clear decrease of the bands representing
(I) chains is observed over 5 days. Processing of the N-propeptide of type I
This is best seen by the accumulation of the bands representing pNα2(I) ch
to control.(BMP-1) and the N-proteinase (ADAMTS2) processing
enzymes in cell culture was examined over a 5-day period
in P1, P3, P4 and P6 and in control samples. Processing
of pN(I)-collagen to mature collagen was delayed in com-
parison to the control sample. This was most clearly vis-
ible for the conversion of pNα2(I)- to α2(I)-collagen. In
contrast, the processing of the C-propeptide occurred at
normal rate (Figure 4).
Molecular findings
In view of the abnormalities in electrophoretic migration
pattern of type I (pro)-collagen, sequencing of COL1A1
and COL1A2 was performed in all probands. These ana-
lyses allowed identification of heterozygous mutations in
the triple helical region close to the procollagen type I
N-proteinase cleavage site in all probands (Table 1,
Figure 5).
In P1 and P2 a COL1A1 missense mutation resulting in
a glycine substitution was identified, in respectively exon 7
(c.563G>A; p.(Gly188Asp)) for P1 and in exon 8
(c. c.607G>T; p.(Gly203Cys)) for P2.
In P4 and P6 a COL1A2 missense mutation resulting
in a glycine substitution was identified, in respectively
exon 8 (c.326G>A; p.(Gly109Asp)) for P4 and exon 12
(c. 587G>T; p.(Gly196Val)) for P6.
In P3, P5 and P7 a COL1A2 mutation resulting in a single
in-frame exon skip was identified, including an exon
skip (c.324+4delA) in P3, an exon 9 skip (c.432+4_
432+7delAGTA) in P5 and an exon 14 skip (c.693+5G>A)
in P7.lse of [3H]-procollagen to collagen was followed over 5 days (d0-d5).
ient with EDS arthrochalasis type due to an exon 6 skip in COL1A2
the pNα2(I) chain and increase of bands representing the mature α2
collagen is delayed in both P1, P4 and in the patient with EDS VIIB.
ains and a slower increase of mature α2(I) chains by day 5, compared
Exon 5 Exon 7 Exon 8 Exon 9 Exon 10 Exon 11 Exon 12 Exon 13 Exon 14 Exon 15COL1A2
skip exon 7
p.(Gly109Asp) p.(Gly196Val)
skip exon 9** skip exon 11°°
skip exon 14skip exon 9
64
Exon 6
p.(Gly188Asp)
Exon 5 Exon 6 Exon 7 Exon 8 Exon 9 Exon 10 Exon 11 Exon 12 Exon 13 Exon 14 Exon 15COL1A1
skip exon 7*
p.(Gly191Asp)* / p.(Gly191Ala)°
p.(Gly203Cys)
p.(Gly211Arg)*
p.(Gly254Glu)*
p.(Gly266Glu)*
p.(Gly203Val)*
2
PROCOLLAGEN N-PROTEINASE
CLEAVAGE SITE
PROCOLLAGEN N-PROTEINASE
CLEAVAGE SITE
1
3 5 7
Figure 5 Schematic localisation of the OI/EDS-associated COL1A1 and COL1A2 mutations reported in the present study (on top of bar)
and previously published (below bar). * [7], ° [14], ** [10,11], °° [8].
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In this study we report on a cohort of patients with an OI/
EDS overlap syndrome resulting from a mutation in the
N-terminal part of the type I collagen helical domain. We
show that, in contrast to what is usually seen for type I
collagen mutations, these patients clinically present as
EDS patients. Indeed, all patients described here share
generalized joint hypermobility and dislocations, skin
hyperextensibility and/or translucency, easy bruising and
(mild) abnormal scarring as the predominant clinical fea-
tures, although invariably associated with mild signs of OI,
including short stature, blue sclerae and osteopenia or in-
frequent fractures. Nevertheless, none of these patients
were clinically diagnosed with OI, suggesting that the fea-
tures resulting from bone fragility were of lesser import-
ance than the features resulting from the soft connective
tissue weakness that is characteristic for EDS. Clinical
overlap with other EDS subtypes, including the classic,
hypermobility, vascular, arthrochalasis and kyphoscoliosis
type, can hamper the correct diagnosis. Therefore, bio-
chemical collagen studies, revealing a processing abnor-
mality of type I (pro-) collagen, are particularly helpful in
the diagnostic evaluation.
Only one study so far exists on patients with an OI/EDS
overlap phenotype, caused by a mutation located within
the 85 most N-terminal amino acids of the α1(I)-collagen
helical region. Six patients with a glycine substitution and
one patient with an exon 7 skip displayed a phenotype
predominantly characterized by severe bone fragility, clin-
ically diagnosed as OI type III or IV, in conjunction with
generalized joint hyperlaxity and early progressive scoli-
osis, which was attributed to severe paraspinal laxity [7].A small number of patients with a mixed OI/EDS pheno-
type has been reported with an exon-skip [8,10-12] or
multi-exon-duplication [9] in the corresponding helical re-
gion of the α2(I)-collagen chain. These mutations cause a
register shift of the mutant chain with respect to the nor-
mal chains. It was previously suggested, based on these
published data, that the α1(I)-mutations in this region
cause severe OI with joint hyperlaxity, whereas the α2(I)-
mutations in the corresponding region result in an EDS
arthrochalasis phenotype [7]. The data from the present
study suggest that this distinction between the α1- and
α2-collagen chain is not so strict, since, on the one hand,
our patients with a COL1A1 mutation display a milder,
more EDS-like phenotype than the patient cohort
reported by Cabral et al. [7] and, on the other hand, no
significant difference in aspect or severity of the OI/EDS
phenotype is observed between the patients with an α1(I)-
versus an α2(I)-chain mutation. It can thus not be pre-
dicted from the phenotype whether the mutation resides
in COL1A1 or COL1A2. Our data also show that, besides
exon skipping mutations, also glycine substitutions in this
region of the α2(I)-collagen chain can be associated with
an OI/EDS overlap phenotype. Our findings are in accord-
ance with the studies from Cabral [7] and Makareeva
et al. [13] who showed that mutations located within the
85 most N-terminal amino acids of the α1(I)- helical do-
main, which acts as a stabilizing “N-anchor” for collagen
folding, result in unfolding of the helix and a conform-
ational change of the adjacent N-propeptide cleavage site,
slowing down the N-propeptide processing by procollagen
I N-proteinase. For all mutations reported here, steady-
state SDS-PAGE of type I procollagen showed abnormal
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that was corroborated by the pulse chase assays. This
delay in N-propeptide processing disturbs normal collagen
fibrillogenesis, resulting in collagen fibrils with smaller di-
ameters and irregular contour, as illustrated in proband
P3. The EDS symptoms in the OI/EDS patients are attrib-
uted to the incomplete or delayed N-propeptide cleavage
and incorporation of the resulting pN-collagen into matrix
fibrils [7]. This hypothesis is corroborated by the observa-
tion that patients presenting with an OI phenotype but no
overt features of EDS, who harbour a mutation within the
same region of the α1- or α2-chain of type I collagen, do
not show delayed type I procollagen N-propeptide pro-
cessing on SDS-PAGE analysis.
It is noteworthy that several patients in this cohort
display signs of vascular fragility, raising a suspicion of
vascular EDS. Interestingly, intracerebral hemorrhage
was reported previously in a OI/EDS patient with an α2
(I)-exon 9 skip [11] and a patient with an α1(I)-p.
(Gly191Ala) substitution was reported to suffer from
multivessel cervical aneurysms [14]. Whether arterial fra-
gility is more frequent in patients with a helical mutation
located near the N-proteinase cleavage site remains to be
determined, since aortic root dilatation, arterial dissec-
tion, and coronary and cerebral artery aneurysms are oc-
casionally encountered in patients with mutations in
other parts of the COL1A1 or COL1A2 gene, although, in
general, they are infrequent [15-17]. Clinical follow-up
studies will be needed to further delineate the natural
history of the phenotype associated these OI/EDS muta-
tions, but awareness for the development of vascular
aneurysm or rupture in childhood and young adulthood
is warranted. In the mean time surgical interventions and
other invasive procedures should be performed with the
utmost care and in consideration of increased risk for
vascular fragility.
Conclusion
In conclusion, we demonstrate that COL1A1 and COL1A2
single exon skips and missense mutations, resulting in gly-
cine substitutions, which are located in the type I collagen
helical domain near the N-propeptide cleavage site, affect
proper N-propeptide processing and result in a mixed OI/
EDS phenotype. Clinically these patients present EDS fea-
tures that overlap with many other EDS subtypes. OI fea-
tures on the other hand may be very mild, and as a result
involvement of type I collagen is not always suspected.
Biochemical collagen analysis is a powerful tool in the
diagnostic work-up of these conditions as it helps in the
differential diagnosis with other EDS subtypes. Further-
more it may point towards type I procollagen processing
defects. Recognition of this distinct phenotype and con-
firmation of the underlying type I collagen defect are
important for accurate genetic counselling, clinicalmanagement and surveillance, particularly in relation to
the risk for vascular fragility.
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